Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Ward

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Sleep|September 20, 2024
Obstructive sleep apnea and cerebral small vessel disease in community-based older people: an aspirin in reducing events in the elderly imaging substudyStephanie A Ward, Elsdon Storey, Matthew T Naughton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
BMJ Open|December 19, 2023
A novel, multidomain, primary care nurse-led and mHealth-assisted intervention for dementia risk reduction in middle-aged adults (HAPPI MIND): study protocol for a cluster randomised controlled trialAmanda J Cross, Gopisankar Mohanannair Geethadevi, Parker Magin, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Identifying dementia risk profiles for targeted interventions: A latent class analysis of at-risk middle-aged AustraliansMuhammad Rehan Sarwar, Amanda J Cross, Kali Godbee, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Sleep|September 20, 2024
Obstructive sleep apnea and cerebral small vessel disease in community-based older people: an aspirin in reducing events in the elderly imaging substudyStephanie A Ward, Elsdon Storey, Matthew T Naughton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
BMJ Open|December 19, 2023
A novel, multidomain, primary care nurse-led and mHealth-assisted intervention for dementia risk reduction in middle-aged adults (HAPPI MIND): study protocol for a cluster randomised controlled trialAmanda J Cross, Gopisankar Mohanannair Geethadevi, Parker Magin, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Identifying dementia risk profiles for targeted interventions: A latent class analysis of at-risk middle-aged AustraliansMuhammad Rehan Sarwar, Amanda J Cross, Kali Godbee, et al.
Pageof 6